China Regenerative Medicine International Ltd
HKEX:8158
Intrinsic Value
China Regenerative Medicine International Ltd. is an investment holding company, which engages in in research and development of medical and healthcare products. [ Read More ]
The intrinsic value of one China Regenerative Medicine International Ltd stock under the Base Case scenario is 0.522 HKD. Compared to the current market price of 0.162 HKD, China Regenerative Medicine International Ltd is Undervalued by 69%.
Valuation Backtest
China Regenerative Medicine International Ltd
Run backtest to discover the historical profit from buying and selling China Regenerative Medicine International Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
China Regenerative Medicine International Ltd
| Current Assets | 168.6m |
| Cash & Short-Term Investments | 3.3m |
| Receivables | 157.6m |
| Other Current Assets | 7.6m |
| Non-Current Assets | 17.3m |
| PP&E | 17.3m |
| Current Liabilities | 147.8m |
| Accounts Payable | 2.5m |
| Accrued Liabilities | 14.9m |
| Other Current Liabilities | 130.4m |
| Non-Current Liabilities | 26.3m |
| Long-Term Debt | 26.2m |
| Other Non-Current Liabilities | 147k |
Earnings Waterfall
China Regenerative Medicine International Ltd
|
Revenue
|
69.5m
HKD
|
|
Cost of Revenue
|
-50.1m
HKD
|
|
Gross Profit
|
19.4m
HKD
|
|
Operating Expenses
|
-126.2m
HKD
|
|
Operating Income
|
-106.8m
HKD
|
|
Other Expenses
|
-929k
HKD
|
|
Net Income
|
-107.7m
HKD
|
Free Cash Flow Analysis
China Regenerative Medicine International Ltd
Profitability Score
Profitability Due Diligence
China Regenerative Medicine International Ltd's profitability score is 18/100. The higher the profitability score, the more profitable the company is.
Score
China Regenerative Medicine International Ltd's profitability score is 18/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
China Regenerative Medicine International Ltd's solvency score is 21/100. The higher the solvency score, the more solvent the company is.
Score
China Regenerative Medicine International Ltd's solvency score is 21/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
China Regenerative Medicine International Ltd
Shareholder Return
Price
China Regenerative Medicine International Ltd
| Average Annual Return | -1.47% |
| Standard Deviation of Annual Returns | 111.36% |
| Max Drawdown | -98% |
| Market Capitalization | 49.3m HKD |
| Shares Outstanding | 304 252 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
China Regenerative Medicine International Ltd. is an investment holding company, which engages in in research and development of medical and healthcare products. Along with subsidiaries, the Company operates its business through four segments. The Medical Equipment segment is involved in trading of medical equipments. The Tissue Engineering segment is involved in production and sale of tissue engineering products. The Cosmetic and Others segment is involved in production and sales of cosmetic, healthcare and other products. The Stem Cell segment is involved in research of cellular and stem cell therapy, sales and distribution of stem cell medical equipment, as well as the provision of other services.
Contact
IPO
Employees
Officers
The intrinsic value of one China Regenerative Medicine International Ltd stock under the Base Case scenario is 0.522 HKD.
Compared to the current market price of 0.162 HKD, China Regenerative Medicine International Ltd is Undervalued by 69%.
You don't have any saved screeners yet
